Whole genome sequencing could match more breast cancer patients to tailored therapies and trials

Whole genome sequencing offered to breast cancer patients is likely to identify unique genetic features that could either guide immediate treatment or help match patients to clinical trials, say scientists at the University of Cambridge. Their research is published in The Lancet Oncology.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup